Krumins S A, Broomfield C A
Biochemical Pharmacology Branch, United States Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland 21010.
Neuropeptides. 1993 Jan;24(1):5-10. doi: 10.1016/0143-4179(93)90035-9.
Incubation of mouse mast cells with C-terminal substance P fragments in the micromolar range caused a release of histamine. Maximum release was observed with the tetrapeptide SP(8-11), followed by the tripeptide SP(9-11). SP(6-11) and SP(5-11) were nearly equipotent, while SP(4-11) caused only a slight histamine release. The substance P parent molecule and the N-terminal substance P fragments SP(1-4), SP(1-6) and SP(1-7) evoked no release of histamine. In confirmation of our previous findings, incubation with neurokinin A caused a release comparable to that of SP(8-11). Whereas neurokinin A-induced release was partially preventable by pretreating the cells with the NK2 receptor-selective antagonist cyclo(Gln-Trp-Phe-(R)Gly[ANC-2]Leu-Met), SP(8-11)-induced release was completely abolished by such treatment. The results provide the first evidence for the involvement of NK2 tachykinin receptors in the release of histamine by C-terminal substance P fragments.
用微摩尔浓度范围的C端P物质片段孵育小鼠肥大细胞会导致组胺释放。用四肽SP(8 - 11)观察到最大释放量,其次是三肽SP(9 - 11)。SP(6 - 11)和SP(5 - 11)几乎等效,而SP(4 - 11)仅引起轻微的组胺释放。P物质母体分子以及N端P物质片段SP(1 - 4)、SP(1 - 6)和SP(1 - 7)未引起组胺释放。为证实我们之前的发现,用神经激肽A孵育导致的释放与SP(8 - 11)相当。虽然用NK2受体选择性拮抗剂环(Gln - Trp - Phe - (R)Gly[ANC - 2]Leu - Met)预处理细胞可部分阻止神经激肽A诱导的释放,但这种处理可完全消除SP(8 - 11)诱导的释放。这些结果首次证明NK2速激肽受体参与C端P物质片段诱导的组胺释放。